The development of highly potent and selective small molecule correctors of Z α1-antitrypsin misfolding
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 41, 127973
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
- GlaxoSmithKline plc
This publication has 8 references indexed in Scilit:
- Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsinEMBO Molecular Medicine, 2021
- Update on alpha-1 antitrypsin deficiency: New therapiesJournal of Hepatology, 2016
- Endoplasmic reticulum polymers impair luminal protein mobility and sensitize to cellular stress in alpha1-antitrypsin deficiencyHepatology, 2012
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticityDrug Discovery Today, 2011
- Design, synthesis and selection of DNA-encoded small-molecule librariesNature Chemical Biology, 2009
- Evaluation of the chemiluminescent nitrogen detector for solubility determinations to support drug discoveryJournal of Pharmaceutical and Biomedical Analysis, 2006
- Ligand efficiency indices as guideposts for drug discoveryDrug Discovery Today, 2005
- The mechanism of Z α1-antitrypsin accumulation in the liverNature, 1992